Cefipime: Difference between revisions

Line 17: Line 17:


==Pediatric Dosing==
==Pediatric Dosing==
====infection, bacterial====
>2 months<br />
50mg/kg IV/IM q12hr, max 2g/dose
====febrile neutropenia====
>2 months<br />
50mg/kg IV/IM q8h; max 2g/dose
====resp. infection, cystic fibrosis pts====
> 2 months<br />
50mg/kg IV/IM q8h; max 2g/dose


==Special Populations==
==Special Populations==

Revision as of 00:39, 3 September 2015

General

  • Type: cephalosporin (4th generation)
  • Dosage Forms: IM/IV
  • Common Trade Names: Maxipime

Adult Dosing

  • 1-2 g IV q12h

febrile neutropenia

  • 2g IV q8h

UTI, mild-mod

  • 0.5g - 1g q12h x 7-10days

UTI, severe

  • 2g IV q12h x 10days

Pediatric Dosing

infection, bacterial

>2 months

50mg/kg IV/IM q12hr, max 2g/dose

febrile neutropenia

>2 months

50mg/kg IV/IM q8h; max 2g/dose

resp. infection, cystic fibrosis pts

> 2 months

50mg/kg IV/IM q8h; max 2g/dose

Special Populations

  • Pregnancy:
  • Lactation:
  • Renal Dosing
    • Adult
    • Pediatric
  • Hepatic Dosing
    • Adult
    • Pediatric

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

See Also

Source